A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis
Authors:
- 30 July 2006
- journal article
- letter
- Published by Springer Nature in Nature Medicine
- Vol. 12 (8) , 945-949
Abstract
The t(8;21)(q22;q22) translocation is one of the most common genetic abnormalities in acute myeloid leukemia (AML), identified in 15% of all cases of AML, including 40–50% of FAB M2 subtype and rare cases of M0, M1 and M4 subtypes1,2,3,4. The most commonly known AML1-ETO fusion protein (full-length AML1-ETO) from this translocation has 752 amino acids and contains the N-terminal portion of RUNX1 (also known as AML1, CBFα2 or PEBP2αB), including its DNA binding domain, and almost the entire RUNX1T1 (also known as MTG8 or ETO) protein5. Although alterations of gene expression and hematopoietic cell proliferation have been reported in the presence of AML1-ETO, its expression does not lead to the development of leukemia6,7,8,9. Here, we report the identification of a previously unknown alternatively spliced isoform of the AML1-ETO transcript, AML1-ETO9a, that includes an extra exon, exon 9a, of the ETO gene. AML1-ETO9a encodes a C-terminally truncated AML1-ETO protein of 575 amino acids. Expression of AML1-ETO9a leads to rapid development of leukemia in a mouse retroviral transduction–transplantation model. More importantly, coexpression of AML1-ETO and AML1-ETO9a results in the substantially earlier onset of AML and blocks myeloid cell differentiation at a more immature stage. These results indicate that fusion proteins from alternatively spliced isoforms of a chromosomal translocation may work together to induce cancer development.Keywords
This publication has 30 references indexed in Scilit:
- Deletion of an AML1-ETO C-terminal NcoR/SMRT-interacting region strongly induces leukemia developmentProceedings of the National Academy of Sciences, 2004
- The 8;21 translocation in leukemogenesisOncogene, 2004
- Role of RUNX family members in transcriptional repression and gene silencingOncogene, 2004
- Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in miceBlood, 2002
- AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AMLOncogene, 2001
- AML1/CBFβ transcription complex: its role in normal hematopoiesis and leukemiaLeukemia, 2001
- Cytogenetically cryptic AML1-ETO and CBFbeta-MYH11 gene rearrangements: incidence in 412 cases of acute myeloid leukaemiaBritish Journal of Haematology, 2000
- Disease Features in Acute Myeloid Leukemia with t(8;21)(q22;q22). Influence of Age, Secondary Karyotype Abnormalities, CD19 Status, and Extramedullar Leukemia on SurvivalLeukemia & Lymphoma, 2000
- Incidence of AML1/ETO fusion transcripts in patients entered into the MRC AML trialsBritish Journal of Haematology, 1997
- The t(8;21) Fusion Protein Interferes with AML-1B-Dependent Transcriptional ActivationMolecular and Cellular Biology, 1995